Impact of atorvastatin treatment in first-degree relatives of patients with premature coronary artery disease with endothelial dysfunction: A double-blind, randomized, placebo-controlled crossover trial

Medicine and Dentistry

• Therapeutic Procedure 100%
• Atorvastatin 80%
• Endothelial Dysfunction 70%
• Coronary Artery Disease 60%
• Prematurity 60%
• Patient 50%
• Placebo 50%
• Hyperaemia 30%
• Cardiovascular System 20%
• Amaurosis 20%
• Low Density Lipoprotein Cholesterol 10%
• Lipid 10%
• Endothelial Function 10%
• Cholesterol 10%
• High Risk Population 10%
• Pulse Wave Velocity 10%
• Primary Prevention 10%
• Family History 10%
• Statin 10%
• Age 10%
• Male 10%
• Adult 10%